Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. The company's manufacturing platform uses single-cell precision to create personalized cell therapy products intended to replace a patient's diseased blood and immune system with a healthy one. At Orca Bio, we are on a mission to redefine what's possible for patients by transforming the field of curative allogeneic cell therapy.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
01/09/26	$250,000,000	Series F	Lightspeed Venture Partners	undisclosed